91 related articles for article (PubMed ID: 23213946)
1. The impact of the vitamins A, C and E in the prevention of gastroesophageal reflux disease, Barrett's oesophagus and oesophageal adenocarcinoma.
Lukić M; Segec A; Segec I; Pinotić L; Pinotić K; Atalić B; Solić K; Vcev A
Coll Antropol; 2012 Sep; 36(3):867-72. PubMed ID: 23213946
[TBL] [Abstract][Full Text] [Related]
2. The role of the nutrition in the pathogenesis of gastroesophageal reflux disease, Barrett's oesophagus and oesophageal adenocarcinoma.
Lukić M; Segec A; Segeca I; Pinotić L; Pinotić K; Atalić B; Solić K; Vcev A
Coll Antropol; 2010 Sep; 34(3):905-9. PubMed ID: 20977081
[TBL] [Abstract][Full Text] [Related]
3. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
4. Does physical activity protect against the development of gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma? A review of the literature with a meta-analysis.
Lam S; Hart AR
Dis Esophagus; 2017 Nov; 30(11):1-10. PubMed ID: 28881908
[TBL] [Abstract][Full Text] [Related]
5. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
6. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett's esophagus.
Murphy SJ; Anderson LA; Ferguson HR; Johnston BT; Watson PR; McGuigan J; Comber H; Reynolds JV; Murray LJ; Cantwell MM
J Nutr; 2010 Oct; 140(10):1757-63. PubMed ID: 20702746
[TBL] [Abstract][Full Text] [Related]
7. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus.
Kubo A; Corley DA; Jensen CD; Kaur R
Nutr Res Rev; 2010 Dec; 23(2):230-46. PubMed ID: 20624335
[TBL] [Abstract][Full Text] [Related]
8. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
9. A study to determine plasma antioxidant concentrations in patients with Barrett's oesophagus.
Clements DM; Oleesky DA; Smith SC; Wheatley H; Hullin DA; Havard TJ; Bowrey DJ
J Clin Pathol; 2005 May; 58(5):490-2. PubMed ID: 15858119
[TBL] [Abstract][Full Text] [Related]
10. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma.
Tsibouris P; Hendrickse MT; Isaacs PE
Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913
[TBL] [Abstract][Full Text] [Related]
11. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
12. Barrett's esophagus in patients with gastroesophageal reflux disease. Medical therapy or antireflux surgery?
Klaus A; Mühlmann G; Kirchmayr W; Weiss H; Wetscher GJ
Minerva Chir; 2002 Aug; 57(4):397-402. PubMed ID: 12145570
[TBL] [Abstract][Full Text] [Related]
13. Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?
Blackett KL; Siddhi SS; Cleary S; Steed H; Miller MH; Macfarlane S; Macfarlane GT; Dillon JF
Aliment Pharmacol Ther; 2013 Jun; 37(11):1084-92. PubMed ID: 23600758
[TBL] [Abstract][Full Text] [Related]
14. Barrett's oesophagus and carcinoma. Recent insights into its development and possible prevention.
Peters FT; Kleibeuker JH
Scand J Gastroenterol Suppl; 1993; 200():59-64. PubMed ID: 8016573
[TBL] [Abstract][Full Text] [Related]
15. Dietary antioxidants and risk of Barrett's esophagus and adenocarcinoma of the esophagus in an Australian population.
Ibiebele TI; Hughes MC; Nagle CM; Bain CJ; Whiteman DC; Webb PM;
Int J Cancer; 2013 Jul; 133(1):214-24. PubMed ID: 23292980
[TBL] [Abstract][Full Text] [Related]
16. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
17. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
Incarbone R; Bonavina L; Bassi F; Peracchia A
Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
[TBL] [Abstract][Full Text] [Related]
18. Review article: Barrett's oesophagus and carcinoma in Japan.
Hongo M
Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
[TBL] [Abstract][Full Text] [Related]
19. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
[TBL] [Abstract][Full Text] [Related]
20. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
Morris CD; Byrne JP; Armstrong GR; Attwood SE
Br J Surg; 2001 Oct; 88(10):1357-62. PubMed ID: 11578292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
